On Open-Label Study in Participants With Systemic Lupus Erythematosus

Summary

The purpose of this SLE study is to evaluate the long-term safety and efficacy of LY2127399 in eligible SLE participants who have completed the core studies (NCT01196091) (NCT01205438).

Timeline

Start

2012-01

Primary completion

2015-10

Completion

2015-10

Drugs

Indications